Children and Adolescents With Localised Non‐Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS‐96 and CWS‐2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry

Complete resection alone is sufficient to cure low-risk NRSTS. Survival was not improved by dose-intensified adjuvant chemotherapy (with/without maintenance treatment). Patients with completely resected high-risk disease may not profit from adjuvant radiotherapy.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-11-11
DOI
https://doi.org/10.1002/pbc.32159
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Children and Adolescents With Localised Non‐Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS‐96 and CWS‐2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry

Semi Harrabi, Thomas Klingebiel, Kristian W. Pajtler, Ruth Lydia Ladenstein et al.
Pediatric Blood & Cancer
Sarcoma Diagnosis and Treatment
article

Children and Adolescents With Localised Non‐Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS‐96 and CWS‐2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry

Semi Harrabi, Thomas Klingebiel, Kristian W. Pajtler, Ruth Lydia Ladenstein, Martin Ebinger, Roland Imle, Sabine Stegmaier, Bernarda Kazanowska, Anton Schönstein, Ines B. Brecht, Jörg Fuchs, Hanna Juntti, Gustaf Ljungman, Monika Sparber‐Sauer, Amadeus T. Heinz, Ewa Kościelniak, Christian Vokuhl
article en

Abstract

Complete resection alone is sufficient to cure low-risk NRSTS. Survival was not improved by dose-intensified adjuvant chemotherapy (with/without maintenance treatment). Patients with completely resected high-risk disease may not profit from adjuvant radiotherapy.

Pediatric Blood & CancerVol. 73(2)
Goethe University Frankfurt (DE), Uppsala University Hospital (SE), University of Bonn (DE), German Cancer Research Center (DE), Heidelberg University (DE), Oulu University Hospital (FI), University Hospital Bonn (DE), University Hospital Heidelberg (DE), Wroclaw Medical University (PL), Heidelberger Institut für Radioonkologie (DE), National Center for Tumor Diseases (DE), Olgahospital (DE), Hopp Children's Cancer Center Heidelberg (DE), St Anna Children's Hospital (AT), University Children's Hospital Tübingen (DE), University Hospital Frankfurt (DE), Klinikum Stuttgart (DE), University of Tübingen (DE)
Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe
Openalex Percentile: Top 51%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.